Literature DB >> 23114759

The target of daptomycin is absent from Escherichia coli and other gram-negative pathogens.

Christopher P Randall1, Katherine R Mariner, Ian Chopra, Alex J O'Neill.   

Abstract

Antistaphylococcal agents commonly lack activity against Gram-negative bacteria like Escherichia coli owing to the permeability barrier presented by the outer membrane and/or the action of efflux transporters. When these intrinsic resistance mechanisms are artificially compromised, such agents almost invariably demonstrate antibacterial activity against Gram negatives. Here we show that this is not the case for the antibiotic daptomycin, whose target appears to be absent from E. coli and other Gram-negative pathogens.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23114759      PMCID: PMC3535891          DOI: 10.1128/AAC.02005-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  Antimicrobial activity and mechanisms of resistance to cephalosporin P1, an antibiotic related to fusidic acid.

Authors:  A J O'Neill; J M Bostock; A Morais Moita; I Chopra
Journal:  J Antimicrob Chemother       Date:  2002-12       Impact factor: 5.790

Review 2.  Agents that increase the permeability of the outer membrane.

Authors:  M Vaara
Journal:  Microbiol Rev       Date:  1992-09

3.  Staphylococcus aureus SH1000 and 8325-4: comparative genome sequences of key laboratory strains in staphylococcal research.

Authors:  A J O'Neill
Journal:  Lett Appl Microbiol       Date:  2010-06-10       Impact factor: 2.858

4.  Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug-resistant strains of Acinetobacter baumannii.

Authors:  N C Gordon; K Png; D W Wareham
Journal:  Antimicrob Agents Chemother       Date:  2010-09-27       Impact factor: 5.191

5.  Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps.

Authors:  Jürgen A Bohnert; Winfried V Kern
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

Review 6.  Antibiotic adjuvants: multicomponent anti-infective strategies.

Authors:  Lindsay Kalan; Gerard D Wright
Journal:  Expert Rev Mol Med       Date:  2011-02-23       Impact factor: 5.600

7.  A forward chemical screen identifies antibiotic adjuvants in Escherichia coli.

Authors:  Patricia L Taylor; Laura Rossi; Gianfranco De Pascale; Gerard D Wright
Journal:  ACS Chem Biol       Date:  2012-06-22       Impact factor: 5.100

8.  Structural transitions as determinants of the action of the calcium-dependent antibiotic daptomycin.

Authors:  David Jung; Annett Rozek; Mark Okon; Robert E W Hancock
Journal:  Chem Biol       Date:  2004-07

9.  Anti-staphylococcal activity and mode of action of clofazimine.

Authors:  Brunello Oliva; Alexander John O'Neill; Keith Miller; William Stubbings; Ian Chopra
Journal:  J Antimicrob Chemother       Date:  2004-02-04       Impact factor: 5.790

10.  A phenylalanine-arginine beta-naphthylamide sensitive multidrug efflux pump involved in intrinsic and acquired resistance of Campylobacter to macrolides.

Authors:  Laurent Mamelli; Jean-Pierre Amoros; Jean-Marie Pagès; Jean-Michel Bolla
Journal:  Int J Antimicrob Agents       Date:  2003-09       Impact factor: 5.283

View more
  42 in total

Review 1.  Molecular mechanisms of antibiotic resistance.

Authors:  Jessica M A Blair; Mark A Webber; Alison J Baylay; David O Ogbolu; Laura J V Piddock
Journal:  Nat Rev Microbiol       Date:  2014-12-01       Impact factor: 60.633

2.  Physical properties of Escherichia coli spheroplast membranes.

Authors:  Yen Sun; Tzu-Lin Sun; Huey W Huang
Journal:  Biophys J       Date:  2014-11-04       Impact factor: 4.033

3.  Synergistic Activity of Colistin-Containing Combinations against Colistin-Resistant Enterobacteriaceae.

Authors:  Thea Brennan-Krohn; Alejandro Pironti; James E Kirby
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

4.  A Universal Culture Medium for Screening Polymyxin-Resistant Gram-Negative Isolates.

Authors:  Patrice Nordmann; Aurélie Jayol; Laurent Poirel
Journal:  J Clin Microbiol       Date:  2016-03-16       Impact factor: 5.948

Review 5.  Mechanism of Action and Resistance to Daptomycin in Staphylococcus aureus and Enterococci.

Authors:  William R Miller; Arnold S Bayer; Cesar A Arias
Journal:  Cold Spring Harb Perspect Med       Date:  2016-11-01       Impact factor: 6.915

6.  Repurposing niclosamide as a versatile antimicrobial surface coating against device-associated, hospital-acquired bacterial infections.

Authors:  Tinotenda Gwisai; Nisha Rosita Hollingsworth; Sarah Cowles; Nagendran Tharmalingam; Eleftherios Mylonakis; Beth Burgwyn Fuchs; Anita Shukla
Journal:  Biomed Mater       Date:  2017-07-12       Impact factor: 3.715

7.  Clofazimine Reduces the Survival of Salmonella enterica in Macrophages and Mice.

Authors:  Toni A Nagy; Amy L Crooks; Joaquin L J Quintana; Corrella S Detweiler
Journal:  ACS Infect Dis       Date:  2020-04-29       Impact factor: 5.084

8.  Potentiation of Antibiotic Activity by a Novel Cationic Peptide: Potency and Spectrum of Activity of SPR741.

Authors:  David Corbett; Andrew Wise; Tara Langley; Kirsty Skinner; Emily Trimby; Stephen Birchall; Alain Dorali; Stephanie Sandiford; Jennifer Williams; Peter Warn; Martti Vaara; Troy Lister
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

Review 9.  A current perspective on daptomycin for the clinical microbiologist.

Authors:  Romney M Humphries; Simon Pollett; George Sakoulas
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

10.  In vitro activity of daptomycin in combination with low-dose colistin against a diverse collection of Gram-negative bacterial pathogens.

Authors:  L Phee; M Hornsey; D W Wareham
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-23       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.